Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bazian is a leading provider of evidence-based medicine (EBM) and health technology assessment (HTA) services, specializing in the rigorous appraisal of clinical evidence. The company supports healthcare payers, providers, and life sciences organizations by translating complex clinical data into actionable insights for policy and practice. Bazian is widely recognized for its 'Behind the Headlines' service for the UK National Health Service (NHS), which provides independent analysis of health news. In 2012, the company was acquired by The Economist Intelligence Unit (EIU), integrating its expertise into EIU Healthcare to offer broader health informatics and strategic consulting. Its core services include systematic reviews, clinical guideline development, and value-based healthcare analysis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bazian.